Business News Asia: Chinese Biotech Firm ImmVira Raises Series C Funding
January 4, 2021
O’Melveny guided biotechnology platform ImmVira Group Company in its recent Series C round led by Greater Bay Area Homeland Development Fund.
Business News Asia reported ImmVira intends to use the capital to fund its pipeline of oncolytic virus and vector type drugs in its effort to create safer therapies against cancer.
Read the full article here.